| Choosing a drug manufacturing site based on a product's point in the life cycle benefits patients, first by enabling rapid, reliable access to new therapeutics, and later by driving down the cost of mature products. The challenge is to find production sites that cater to both the specific priorities faced at different points in the life cycle and the universal requirements that apply to all products at all times. In this white paper, the experts at Piramal Pharma Solutions explain how a contract development & manufacturing organization can support biopharma companies as their product needs evolve. For late life cycle drugs that can benefit from reduced costs, India often represents a solution; for approved or near-approved drugs that are expected to sell in large volumes, Western resources that are on shore and close to the market may be the answer. To learn more about our late life cycle tech transfer capabilities, contact us. | 